CA Stock MarketDetailed Quotes

TTI Thiogenesis Therapeutics Corp

Watchlist
  • 0.680
  • 0.0000.00%
15min DelayMarket Closed Sep 27 16:00 ET
30.94MMarket Cap-6181P/E (TTM)

Thiogenesis Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
7.06%4.97M
3.86%5.52M
14.21%7.08M
14.21%7.08M
125.03%3.63M
--4.64M
51.86%5.32M
9,805.77%6.2M
9,805.77%6.2M
2,071.09%1.61M
-Cash and cash equivalents
7.06%4.97M
3.86%5.52M
14.21%7.08M
14.21%7.08M
125.03%3.63M
--4.64M
51.86%5.32M
9,805.77%6.2M
9,805.77%6.2M
2,071.09%1.61M
-Accounts receivable
-89.52%1.32K
-63.13%6.99K
-17.97%6K
-17.97%6K
-90.77%1.99K
-41.55%12.63K
525.19%18.96K
-44.62%7.32K
-44.62%7.32K
2,835.05%21.56K
Total current assets
7.78%5.06M
6.38%5.69M
15.14%7.24M
15.14%7.24M
125.40%3.69M
110.06%4.7M
52.53%5.35M
2,623.46%6.29M
2,623.46%6.29M
1,475.40%1.64M
Non current assets
Regulatory assets
0.88%47.56K
404.29%95.62K
52.38%85.32K
52.38%85.32K
110.04%45.29K
118.22%47.15K
525.19%18.96K
-66.76%55.99K
-66.76%55.99K
2,835.05%21.56K
Total assets
33.95%46.24K
--88.63K
469.48%79.31K
469.48%79.31K
--43.3K
--34.52K
----
--13.93K
--13.93K
----
Liabilities
Current liabilities
-Total tax payable
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Current liabilities
-11.83%308.45K
33.57%344.6K
457.66%1.71M
457.66%1.71M
295.94%320.44K
404.69%349.83K
-74.97%258K
-76.25%307.15K
-76.25%307.15K
-90.23%80.93K
Non current liabilities
Total non current liabilities
-11.83%308.45K
33.57%344.6K
457.66%1.71M
457.66%1.71M
295.94%320.44K
404.69%349.83K
-74.97%258K
-76.25%307.15K
-76.25%307.15K
-90.23%80.93K
Shareholders'equity
Share capital
40.69%15.66M
40.69%15.66M
34.89%15.01M
34.89%15.01M
70.84%11.13M
70.97%11.13M
75.12%11.13M
957.18%11.13M
957.18%11.13M
425,462.77%6.51M
-common stock
40.69%15.66M
40.69%15.66M
34.89%15.01M
34.89%15.01M
70.84%11.13M
70.97%11.13M
75.12%11.13M
957.18%11.13M
957.18%11.13M
425,462.77%6.51M
Gains losses not affecting retained earnings
19.76%1.6M
27.44%1.54M
60.52%1.66M
60.52%1.66M
121.25%1.41M
143.62%1.34M
135.16%1.2M
3,505.03%1.03M
3,505.03%1.03M
-50.71%635.75K
Total equity
7.78%5.06M
6.38%5.69M
15.14%7.24M
15.14%7.24M
125.40%3.69M
110.06%4.7M
52.53%5.35M
2,623.46%6.29M
2,623.46%6.29M
1,475.40%1.64M
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 7.06%4.97M3.86%5.52M14.21%7.08M14.21%7.08M125.03%3.63M--4.64M51.86%5.32M9,805.77%6.2M9,805.77%6.2M2,071.09%1.61M
-Cash and cash equivalents 7.06%4.97M3.86%5.52M14.21%7.08M14.21%7.08M125.03%3.63M--4.64M51.86%5.32M9,805.77%6.2M9,805.77%6.2M2,071.09%1.61M
-Accounts receivable -89.52%1.32K-63.13%6.99K-17.97%6K-17.97%6K-90.77%1.99K-41.55%12.63K525.19%18.96K-44.62%7.32K-44.62%7.32K2,835.05%21.56K
Total current assets 7.78%5.06M6.38%5.69M15.14%7.24M15.14%7.24M125.40%3.69M110.06%4.7M52.53%5.35M2,623.46%6.29M2,623.46%6.29M1,475.40%1.64M
Non current assets
Regulatory assets 0.88%47.56K404.29%95.62K52.38%85.32K52.38%85.32K110.04%45.29K118.22%47.15K525.19%18.96K-66.76%55.99K-66.76%55.99K2,835.05%21.56K
Total assets 33.95%46.24K--88.63K469.48%79.31K469.48%79.31K--43.3K--34.52K------13.93K--13.93K----
Liabilities
Current liabilities
-Total tax payable --0--0--0--0--0--0--0--0--0--0
Current liabilities -11.83%308.45K33.57%344.6K457.66%1.71M457.66%1.71M295.94%320.44K404.69%349.83K-74.97%258K-76.25%307.15K-76.25%307.15K-90.23%80.93K
Non current liabilities
Total non current liabilities -11.83%308.45K33.57%344.6K457.66%1.71M457.66%1.71M295.94%320.44K404.69%349.83K-74.97%258K-76.25%307.15K-76.25%307.15K-90.23%80.93K
Shareholders'equity
Share capital 40.69%15.66M40.69%15.66M34.89%15.01M34.89%15.01M70.84%11.13M70.97%11.13M75.12%11.13M957.18%11.13M957.18%11.13M425,462.77%6.51M
-common stock 40.69%15.66M40.69%15.66M34.89%15.01M34.89%15.01M70.84%11.13M70.97%11.13M75.12%11.13M957.18%11.13M957.18%11.13M425,462.77%6.51M
Gains losses not affecting retained earnings 19.76%1.6M27.44%1.54M60.52%1.66M60.52%1.66M121.25%1.41M143.62%1.34M135.16%1.2M3,505.03%1.03M3,505.03%1.03M-50.71%635.75K
Total equity 7.78%5.06M6.38%5.69M15.14%7.24M15.14%7.24M125.40%3.69M110.06%4.7M52.53%5.35M2,623.46%6.29M2,623.46%6.29M1,475.40%1.64M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data